Seres Therapeutics, Inc. (MCRB) › Shareholders' EquitySeres Therapeutics, Inc. (MCRB) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2012: -$4.35M2013: -$11.12M2014: -$26.72M2015: $205.39M2016: $132.63M2017: $60.70M2018: -$48.05M2019: -$48.32M2020: $174.75M2021: $131.51M2022: $10.78M2023: -$44.86M2024: $13.78M2025: $44.22M$44.22M2012Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$44.22M+220.8%2024$13.78M+130.7%2023-$44.86M-516.0%2022$10.78M-91.8%2021$131.51M-24.7%2020$174.75M+461.6%2019-$48.32M-0.6%2018-$48.05M-179.2%2017$60.70M-54.2%2016$132.63M-35.4%2015$205.39M+868.7%2014-$26.72M-140.4%2013-$11.12M-155.7%2012-$4.35M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share